|Mr. Paul R. Gudonis||Chairman, Pres & CEO||244.75k||N/A||1955|
|Mr. David A. Henry||Chief Financial Officer||210.92k||N/A||1961|
|Mr. Jonathan Naft||VP & GM||200k||N/A||1965|
|Mr. Clifford J. Conneighton||Chief Marketing Officer||N/A||N/A||1950|
|Dr. Brandon Green DO, BOCP||Chief Medical Officer||N/A||N/A||1983|
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis used for the purpose of supporting a patient's weak or deformed arm to enable and improve functional activities of daily living, ADLs, in the home and community. Its products are designed to help restore function in individuals with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, rehabilitation hospitals, and through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Cambridge, Massachusetts.
Myomo, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.